Delivery Order SPE2DB25D3504-SPE2DB25FVVSD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,798.98 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vial (10 mL) on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,903.68 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vial (10 ML) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,585.44 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vials (10 mL) on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The order represents a child contract action under AmerisourceBergen's broader indefinite...
- The Defense Logistics Agency awarded a $2,796.14 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies vaccines, medications, medical devices, and...
- The Defense Logistics Agency awarded a delivery order valued at $2,069.70 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was issued on July 21, 2025, and the product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,827.28 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 31, 2025, with completion targeted for August 1, 2025. This firm fixed price delivery order, awarded without set-aside designation through competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- On July 23, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,035.56 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes (0.5 ML). This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 24, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order valued at $51,797.40 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML vials (10 ML units). This is a firm fixed-price delivery order with a completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $1,379.80. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $10.75K with a completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a small-value transaction within AmerisourceBergen's broader pharmaceutical distribution portfolio. The place of performance is located in Conshohocken, Pennsylvania, where the company...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVVSDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,756.97 to AmerisourceBergen Drug Corp for TYPHIM VI 25 mcg/0.5 ml vial (10 ml) on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support, enabling the company to deliver medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The contract serves customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key vendor within the DLA's pharmaceutical supply chain and supporting the broader Defense Health Agency mission.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/28/25 |